Experiences of a National Sample of Qualified Addiction Specialists Who Have and Have Not Prescribed Buprenorphine for Opioid Dependence
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The limited availability of medication-assisted treatment has created a treatment gap leaving many opioid dependent individuals without access to appropriate treatment. Survey data from a national random sample of 545 addictions physicians with waivers to provide buprenorphine treatment under The Drug Addiction Treatment Act of 2000 are presented. During the first year, an estimated 63,204 opioid dependent patients were treated with buprenorphine; many were dependent on prescription opioids and were new to drug treatment. Prescribing physicians reported high treatment effectiveness and patient satisfaction, with minimal adverse reactions or evidence of diversion. However, many waivered physicians had not provided buprenorphine treatment. Prescribers identified challenges such as induction logistics, recordkeeping requirements, the 30-patient limit, DEA involvement, and limited patient compliance. Buprenorphine treatment could potentially reduce the treatment gap by providing safe and effective treatment for opioid dependence and by attracting patients who do not typically seek care at opioid treatment programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402
Office-Based Treatment of Opioid-Dependent Patients
Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148
Vignau, J., Duhamel, A., Catteau, J., Legal, G., Huynh, A., Grailles, I., Beauvillain, J., Petit, P., Beauvillain, P., & Parquet, P. J. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00189-1 · Cited by 39
Cited by
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Co-occurring substance use and mental disorders among adults with opioid use disorder
Jones, C. M., & McCance-Katz, E. F. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.12.030 · Cited by 464
Why aren't physicians prescribing more buprenorphine?
Huhn, A. S., & Dunn, K. E. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.04.005 · Cited by 291
Barriers to Primary Care Physicians Prescribing Buprenorphine
Hutchinson, E., Catlin, M., Andrilla, C. H. A., Baldwin, L.-M., & Rosenblatt, R. A. (2014) · The Annals of Family Medicine · doi:10.1370/afm.1595 · Cited by 289
Dunn, K. E., Sigmon, S. C., Strain, E. C., Heil, S. H., & Higgins, S. T. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.033 · Cited by 65
“subgroup of opioid-dependent patients who are younger and have briefer and less severe opioid use histories compared to traditional heroin-dependent patients, which could make them good candidates for detoxification, or even ineligible for agonist maintenance (Fiellin, 2007; Kissin et al., 2006; Sullivan et al., 2005).”
Background
Metadata
- Authors
- Kissin, W., McLeod, C., Sonnefeld, J., & Stanton, A.
- Venue
- Journal of Addictive Diseases
- Publisher
- Informa UK Limited
- Published
- 2006-11-02
- Volume
- 25
- Issue
- 4
- Pages
- 91-103
- ISSN
- 1055-0887 (ISSN-L)
- 1545-0848
- OpenAlex
- W1970347370
- Cited by
- 108
- References
- 4
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.